Alcista
$0.97
Precio del escenario
$2.210
-0.105 (-4.74%)Al cierre
SANGRIX INC., formerly Bit Origin Ltd, is a Singapore-based company focused on artificial intelligence (AI) computing infrastructure and related digital infrastructure opportunities. The Company is evaluating and pursuing opportunities involving graphics processing unit (GPU) computing, server leasing, storage infrastructure and related services. The Company is also managing its digital assets and legacy operations.
Bit Origin Ltd is currently not a good buy due to its significant decline in value, with a year-to-date change of -94.42% and a current RSI of 30.189 indicating oversold conditions. While the company has regained compliance with NASDAQ's minimum bid price criteria, which could enhance investor confidence, the overall financial metrics show a concerning forward P/E of 0 and a price-to-sales ratio of 74.801, suggesting overvaluation. The main risk is the company's negative cash flow, with a price to free cash flow of -0.787, indicating potential liquidity issues.
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Bit Origin Announces 1-for-5 Reverse Stock Split

Global AI Infrastructure Spending to Reach $497 Billion

Bit Origin Ltd Proposes Name Change to SANGRIX

Bit Origin Updates on AI Infrastructure Progress

Bit Origin Shares Surge After $11M Nvidia AI Asset Acquisition
SANGRIX INC., formerly Bit Origin Ltd, is a Singapore-based company focused on artificial intelligence (AI) computing infrastructure and related digital infrastructure opportunities. The Company is evaluating and pursuing opportunities involving graphics processing unit (GPU) computing, server leasing, storage infrastructure and related services. The Company is also managing its digital assets and legacy operations. It operates in the Consumer Non-Cyclicals sector.
Bit Origin Ltd is currently not a good buy due to its significant decline in value, with a year-to-date change of -94.42% and a current RSI of 30.189 indicating oversold conditions. While the company has regained compliance with NASDAQ's minimum bid price criteria, which could enhance investor confidence, the overall financial metrics show a concerning forward P/E of 0 and a price-to-sales ratio of 74.801, suggesting overvaluation. The main risk is the company's negative cash flow, with a price to free cash flow of -0.787, indicating potential liquidity issues.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.